GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) first isolated from human plasma. Serum levels drop roughly 60% between age 20 and age 60, which is the core rationale for exogenous replacement. Its activity is inseparable from its copper cargo — GHK is the delivery vehicle, Cu²⁺ is much of the payload — and together they act as a matrix-signaling molecule that rewires fibroblast behavior, angiogenesis, and gene expression toward a more youthful tissue profile.

Copper Delivery and Fibroblast Activation#

The defining mechanism is selective copper transfer into cells. GHK has a higher affinity for Cu²⁺ than serum albumin does, so it effectively pulls copper off albumin and hands it to cellular copper chaperones and cuproenzymes — lysyl oxidase, superoxide dismutase, cytochrome c oxidase — that run ECM crosslinking, redox defense, and mitochondrial respiration.

"The growth-modulating tripeptide GHK appears to function by increasing the uptake of copper into cells." — Pickart L., Freedman J.H., et al. Nature, 1980

Practically, this is why GHK-Cu outperforms free GHK or plain copper salts: it's the chaperoned delivery that drives the downstream signaling.

ECM Remodeling: Collagen, Elastin, GAGs#

In dermal fibroblasts, GHK-Cu upregulates type I and III collagen, elastin, decorin, and glycosaminoglycan synthesis while simultaneously activating matrix metalloproteinases (MMP-1, MMP-2) and their tissue inhibitors (TIMPs). The net effect is not "more collagen piled on top" — it's coordinated remodeling: degrading disorganized, glycated, photo-damaged matrix and replacing it with new, properly crosslinked fibers. This is the mechanism behind the skin-quality, post-laser recovery, and tendon/ligament rehab use cases.

"GHK-Cu improved skin quality, stimulated hair growth, accelerated wound healing, and had antioxidant and anti-inflammatory effects." — Pickart L., Margolina A. International Journal of Molecular Sciences, 2018

Angiogenesis and Nerve Outgrowth#

GHK-Cu stimulates VEGF expression and capillary formation at application sites, improving perfusion into remodeling tissue. It also supports nerve outgrowth in cutaneous and peripheral tissue. For lifters running it alongside BPC-157 and TB-500 in an injury block, this angiogenic signal layers cleanly with BPC-157's vascular effects and TB-500's cell-migration mechanics — the reason the "healing trio" has stuck around.

Gene Expression Reprogramming#

The most striking mechanism is transcriptional. Analysis in the Broad Institute's Connectivity Map showed GHK modulates expression of ~4,000 human genes — roughly 31% upregulated, 63% downregulated — with consistent shifts in DNA-repair, antioxidant defense, inflammatory signaling, and fibrotic pathways.

"GHK influenced the expression of about 4,000 human genes, shifting their expression from a diseased or aged state toward a healthier profile." — Pickart L., Vasquez-Soltero J.M., Margolina A. BioMed Research International, 2014

This is why the effects look broader than a simple "collagen peptide" story: DNA-repair genes go up, TGF-β–driven fibrosis pathways come down, antioxidant enzymes are induced. It explains the longevity-adjacent framing the compound has picked up in the looksmaxxing and peptide communities.

Antioxidant and Anti-Inflammatory Signaling#

GHK-Cu quenches hydroxyl radicals, chelates reactive iron (blocking Fenton-reaction damage), suppresses NF-κB signaling, and downregulates pro-inflammatory cytokines like IL-6 and TNF-α. In aged or UV-damaged skin this translates to less chronic low-grade inflammation — the substrate on which photoaging, post-inflammatory hyperpigmentation, and androgenetic follicle miniaturization all compound.

"GHK-Cu suppresses the expression of pro-inflammatory cytokines, scavenges free radicals, and promotes DNA repair." — Pickart L., Vasquez-Soltero J.M., Margolina A. Oxidative Medicine and Cellular Longevity, 2012

Hair Follicle Enlargement#

On the scalp, GHK-Cu drives dermal papilla cell proliferation, VEGF-mediated perifollicular angiogenesis, and prolongation of anagen. In the classic fuzzy-rat model, copper-peptide analogs produced follicle enlargement on par with minoxidil.

"Copper-peptide treatment resulted in follicle enlargement comparable to the effect of minoxidil in fuzzy rats." — Uno H., Kurata S. Journal of Investigative Dermatology, 1993

Important framing: this is a follicle-quality and matrix-support mechanism, not an anti-androgen one. GHK-Cu does nothing to 5α-reductase or the androgen receptor. It's a legitimate adjunct in a hair stack alongside finasteride/dutasteride, topical AR antagonists (RU58841, pyrilutamide), and minoxidil — not a replacement for any of them.

Why Topical Usually Wins for Skin and Hair#

At 340 Da for free GHK (402.9 for the copper complex), the molecule is small enough to cross the stratum corneum when properly formulated in a hydrophilic vehicle — a rare property among peptides. Combined with the short plasma half-life of injected GHK (minutes to ~2 hours before peptidase cleavage and copper redistribution to albumin/ceruloplasmin), this is why topical 1–2% serum beats subcutaneous injection for localized skin and scalp endpoints. Systemic SC dosing is reserved for recovery blocks and whole-body anti-inflammatory use, where the tissue-signaling effects outlast the peptide's time in plasma.

Common (most users)#

• Mild stinging or transient erythema (topical) — usually on first week of use or when the serum concentration is >1.5%. Apply to damp (not wet) skin, start at 1%, and buffer with a ceramide moisturizer 30 seconds after. Resolves on its own.
• Blue-green tint on skin or pillowcase — purely cosmetic, from the copper chromophore. Use less product (one pump is enough for the whole face), let it absorb for 2–3 minutes before moisturizer, and apply at night.
• Injection-site redness, mild welt, or itching (SC) — rotate between left and right abdominal fat, inject at room temperature, and pinch the site rather than flat-stab. Ice the spot for 30 seconds if prone to welts.
• Transient fatigue or mild headache on first few injections — reported anecdotally, typically resolves within the first week as tissue-level signaling settles. Dose pre-bed to sleep through it.

Uncommon (dose-dependent or individual)#

• Contact dermatitis from topical — genuine allergic reaction is rare but real. If you get persistent itching, papules, or worsening redness after >72 h, stop and patch-test on the inner forearm before resuming. Often it's the preservative or base, not the GHK-Cu itself.
• Irritation when stacked with actives on the same night — ascorbic acid (vitamin C), glycolic/lactic acid, benzoyl peroxide, and high-strength retinoids will oxidize the copper complex and amplify irritation. Alternate nights or separate application by ≥30 min.
• Serum copper creep on continuous high-dose systemic use — plausible only with daily mg-level SC dosing run continuously for many months. If you're running that kind of protocol >6 months, pull serum copper and ceruloplasmin. In healthy adults eating a normal diet, it's a non-issue at standard 30-on / 30-off cycling.
• DIY serum going off — not a side effect of the peptide, but a frequent cause of "I reacted to GHK-Cu." Unpreserved or room-temp batches grow bacteria fast. Use Germall Plus (or equivalent), refrigerate, and make small batches.

Rare but serious#

• Systemic copper overload — essentially only seen in people with undiagnosed Wilson's disease or other copper-handling disorders. Warning signs: new tremor, personality changes, jaundice, Kayser-Fleischer rings, unexplained LFT elevations. Stop immediately and get ceruloplasmin + 24 h urinary copper.
• Severe hypersensitivity reaction — theoretical with any peptide. Swelling beyond the injection site, widespread hives, or breathing changes → stop, antihistamine, ER if needed.

No hepatotoxicity, nephrotoxicity, endocrine suppression, or cardiovascular adverse signals have been documented in the human or animal literature at the doses in this protocol.

"GHK-Cu improved skin quality, stimulated hair growth, accelerated wound healing, and had antioxidant and anti-inflammatory effects." — Pickart & Margolina, Int J Mol Sci 2018

Hard contraindications#

• Wilson's disease or any diagnosed copper-metabolism disorder — do not use, topical or injectable. GHK-Cu's entire mechanism is copper delivery into cells.
• Pregnancy and lactation — no safety data. Stop before conception attempts and do not use while nursing.
• Known peptide or copper hypersensitivity — obvious but worth stating.
• Do not co-apply topically with benzoyl peroxide, strong ascorbic acid, or high-strength AHAs in the same application — destroys the complex and produces the irritation most people blame on the peptide.

Gender considerations and PCT#

GHK-Cu is non-hormonal. It does not bind androgen, estrogen, progesterone, or glucocorticoid receptors, does not aromatize, and has no effect on the HPG or HPT axes. Women run the same dose as men (topical 1–2% nightly; injectable 1–2 mg/day SC) with no virilization risk. There is no PCT requirement and no impact on fertility or semen parameters — it pairs cleanly with AAS cycles, SARMs, GH, TRT cruise, or 5-AR inhibitor hair stacks without interfering with any of them. The only women's-health line is pregnancy and lactation, where the rule is simply: no data, don't use.